News
Dr. Cathy Creticos with the Howard Brown Health Center has been at the forefront of HIV and AIDS research and treatment for ...
The Centers for Disease Control and Prevention is the latest agency in the Health and Human Services Department to rehire ...
5d
MedPage Today on MSNPrimary Prevention of Cardiovascular Disease Important in People With HIVPeople living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...
The Trump administration's plan to cut funding for HIV vaccine research comes at a time when the field is making substantial ...
The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...
Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...
The Canadian Press on MSN4d
Doctors, health experts call on N.S. to cover birth control and HIV-prevention drugHALIFAX – Nova Scotia physicians and other sexual health experts who are calling on the provincial government to fund birth ...
3d
GlobalData on MSNGilead hit with FDA clinical hold for batch of HIV trialsDecreasing CD4 and lymphocyte counts in some participants receiving an oral combination therapy led to holds in the study.
The Trump administration's cuts to the U.S. Agency for International Development have had reverberations around the world.
5d
ABC13 Houston on MSNUS Food and Drug Administration to review injectable medication to prevent HIV transmissionThe medication, Lenacapavir, is said to have shown exceptional promise in clinical trials, and some of the research is being conducted here in Houston.
A paper published in Nature Communications says that scientists at the Peter Doherty Institute for Infection and Immunity in ...
Gilead has been hit with a clinical hold from the FDA for five tests of its experimental HIV combination treatment amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results